3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 3
1
Phase 2
1
Status
Completed
4
Recruiting
2
Unknown
1
Terminated
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
3
Neoplasms
2
Myasthenia Gravis
2
Leukemia, Myeloid, Acute
2
Radiodermatitis
1
Neurotoxicity Syndromes
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Gallbladder Neoplasms
1
Fibrosis
1
Esophageal Squamous Cell Carcinoma
1
Depression
1
Cognitive Dysfunction
1
Chemotherapy-Related Cognitive Impairment
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Carcinoma
1
Breast Neoplasms
1
Breast Cancer Metastatic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Enrolling by invitation
×
Cognitive Dysfunction
×
Clear all
NCT06950190
2025-08-12
(ECCPC)
Ellis Medicine
Phase 3
Enrolling by invitation
100 enrolled